magnoflorine has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dabur, R; Dahuja, A; Phogat, J; Singh, A; Yadav, A | 1 |
1 other study(ies) available for magnoflorine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Magnoflorine prevent the skeletal muscle atrophy via Akt/mTOR/FoxO signal pathway and increase slow-MyHC production in streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Aporphines; Autophagy; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Forkhead Transcription Factors; Hypoglycemic Agents; Inflammation Mediators; Male; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Streptozocin; TOR Serine-Threonine Kinases | 2021 |